Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

The Best Treatment for High-Grade T1 Bladder Cancer is Cystectomy - Abstract Show Comments PDF Print E-mail
  
Tuesday, 01 January 2008

Department of Urology, Keck University of Southern California School of Medicine, Los Angeles, CA 90089, USA

To evaluate the role of initial cystectomy in the management of high-grade T1 bladder cancer.

A selected review of the literature was performed to evaluate outcomes with intravesical therapy vs. initial cystectomy in this patient population, with a focus on identifying risk factors for failure of conservative therapy.

Many studies in the literature fail to include central pathologic review and re-TUR clinical staging, and there are no randomized studies comparing outcomes with these two initial approaches. Retrospective studies of patients with high-grade T1 tumors treated with initial intravesical therapy suggest that approximately 30% of patients will ultimately require cystectomy, and 30% will die of their disease with or without cystectomy. The risk of progression continues for the life of the patient, and late recurrence and progression is common. Initial clinical and pathologic factors can be identified that predict a high risk of progression and are reasonable indicators for initial cystectomy.

Radical cystectomy can provide a very high cure rate for these patients and should be considered early in the treatment plan

Written by
Skinner EC.

Reference
Urol Oncol. 2007 Nov-Dec;25(6):523-5
doi:10.1016/j.urolonc.2007.05.023

PubMed Abstract
PMID:18047965

UroToday.com Bladder Cancer Section

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share
< Prev   Next >

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Bladder Cancer
Sponsored By